RJ

Rajesh Jat

Active Director Director DIN 03146756
DIN 03146756 First appointment Sep 2010 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 1 historical roles
Total affiliations 5 Since Sep 2010
Shareholding value •••• Premium profile

About Rajesh Jat

Data last updated:

Rajesh Jat is a Director at Wilburt Remedies Private Limited (since 2012), Director at Wilshire Pharmaceuticals Private Limited (since 2010) and Director at Willcare Lifesciences Private Limited (since 2023), and holds 1 more current directorship. The companies operate in Pharma, Trading and Agriculture. The 3 current companies with reported revenue have a combined latest revenue of ₹46.84 Cr; the largest is Wilburt Remedies Private Limited at ₹18.35 Cr (FY 2023). Earlier, Rajesh Jat was a Director at Wilshire Pesticides & Fertilizer Private Limited (2012–2017).

DIN 03146756
Primary Designation Director
Industry Pharma
First Appointment 08 Sep 2010
Oldest Company Age 16 yrs
Largest company Wilburt Remedies Private Limited · ₹18.35 Cr (FY 2023)
Combined revenue ₹46.84 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Wilburt Remedies Private Limited U24232MP2012PTC028524
Director25 May 20122012₹18.35 Cr (FY 2023)Active
Director08 Sep 20102010₹15.58 Cr (FY 2023)Active
Director14 Apr 20232011₹12.91 Cr (FY 2025)Active
Director06 Sep 20242024Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director16 Oct 20122012₹30.07 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Wilshire Pharmaceuticals Private Limited
Wilburt Remedies Private Limited
Willcare Lifesciences Private Limited
Wilburt Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Rajesh Jat

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajesh Jat

Rajesh Jat currently holds 4 directorships: Wilburt Remedies Private Limited (Director, since 25 May 2012, revenue ₹18.35 Cr (FY 2023)); Wilshire Pharmaceuticals Private Limited (Director, since 08 Sep 2010, revenue ₹15.58 Cr (FY 2023)); Willcare Lifesciences Private Limited (Director, since 14 Apr 2023, revenue ₹12.91 Cr (FY 2025)); Wilburt Pharmaceuticals Private Limited (Director, since 06 Sep 2024).

Rajesh Jat was first appointed on 08 Sep 2010 as Director at Wilshire Pharmaceuticals Private Limited. The most recent appointment on record is 06 Sep 2024 at Wilburt Pharmaceuticals Private Limited.

The 3 current companies of Rajesh Jat that report revenue have a combined latest revenue of ₹46.84 Cr: Wilburt Remedies Private Limited ₹18.35 Cr (FY 2023); Wilshire Pharmaceuticals Private Limited ₹15.58 Cr (FY 2023); Willcare Lifesciences Private Limited ₹12.91 Cr (FY 2025).

Rajesh Jat held 1 earlier board appointment: Wilshire Pesticides & Fertilizer Private Limited (Director, 16 Oct 2012 to 07 Dec 2017).

The current boards of Rajesh Jat's companies include Dharamveer Singh Shaktawat (Wilburt Remedies Private Limited), Pramod Patil (Wilburt Remedies Private Limited), Prashant Singh (Wilburt Remedies Private Limited), Mohd Arif Siddique (Wilshire Pharmaceuticals Private Limited), Mohd Kamil Shah (Wilshire Pharmaceuticals Private Limited), Gururaj Patil (Willcare Lifesciences Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available